ORAGENICS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
ORAGENICS, INC. (OGEN) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$54.16 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2018-02-16
- ORAGENICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-12-31 was -$11.39K.
- ORAGENICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-09-30 was -$144.51K.
- ORAGENICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-06-30 was $163.72K.
- ORAGENICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-03-31 was -$61.97K.
- ORAGENICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2016 was -$54.16K, a 163.63% decline from fiscal 2015.
- ORAGENICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2015 was $85.11K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$11.39K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$155.90K derived: sum of 2 quarters · filed 2018-02-16 | $7.82K derived: sum of 3 quarters · filed 2018-02-16 | -$54.16K 10-K · filed 2018-02-16 |
| 2016-09-30 | -$144.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $19.21K derived: sum of 2 quarters · filed 2017-10-31 | -$42.76K 10-Q · filed 2017-10-31 | |
| 2016-06-30 | $163.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $101.75K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$61.97K 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | $85.11K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |